Arkolith/Insider Trading/DTIL/Form 4

Smith J. Jefferson

Chief Research OfficerPRECISION BIOSCIENCES INC (DTIL) · full profile →Form 4 · filed Jan 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$41K
Net Open-Market Flow
-$41K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)10K$4.03$41K110K
Jan 21, 2026Option exercise(M)16K——120K
Jan 20, 2026Option exercise(M)10K——104K
Jan 20, 2026Option exercise(M)3K——94K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 20, 2026Option exercise(M)3K—$00
Jan 20, 2026Option exercise(M)10K—$010K
Jan 20, 2026Option exercise(M)16K—$016K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-003146) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML